Clinical Trial Update: Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model [NA]

View source ↗

Summary

Completed clinical trial evaluating bone density and bone turnover markers in individuals with Down syndrome and comparing results to the Ts65Dn mouse model.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: University of Arkansas | Conditions: Down Syndrome | NA | Status: COMPLETED